TWC
ICPT

TD Waterhouse Canada’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

TD Waterhouse Canada’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10
Closed -$141 – 1806
2022
Q2 		$141 Buy
+10
New +$160 ﹤0.01% 1708

Other funds holding ICPT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TD Waterhouse Canada's ICPT Position: Q3 2022 in Review

TD Waterhouse Canada sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2022, closing a stake of 10 shares — an estimated $141 sold.

TD Waterhouse Canada first reported a position in ICPT in Q2 2022 and held it in 1 quarter. The position peaked at $141 in Q2 2022. 156 funds tracked by Wall St. Rank hold ICPT as of Q3 2022.

  • TD Waterhouse Canada reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
  • TD Waterhouse Canada sold 10 Intercept Pharmaceuticals, Inc. shares in Q3 2022, an estimated $141.
  • TD Waterhouse Canada first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2022 and held it in 1 quarter.
  • TD Waterhouse Canada's Intercept Pharmaceuticals, Inc. position peaked at $141 in Q2 2022.
  • 156 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2022.

Based on TD Waterhouse Canada's 13F filing for Q3 2022, filed 13 Nov 2023.